Travere Therapeutics Inc (TVTX)
5.80
-0.20
(-3.25%)
USD |
NASDAQ |
Apr 18, 16:00
5.80
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Revenue (Quarterly): 45.06M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.06M |
| September 30, 2023 | 37.10M |
| June 30, 2023 | 59.70M |
| March 31, 2023 | 56.99M |
| December 31, 2022 | 29.34M |
| September 30, 2022 | 28.08M |
| June 30, 2022 | 54.17M |
| March 31, 2022 | 48.49M |
| December 31, 2021 | -38.40M |
| September 30, 2021 | 68.22M |
| June 30, 2021 | 54.62M |
| March 31, 2021 | 47.41M |
| December 31, 2020 | 50.98M |
| September 30, 2020 | 51.14M |
| June 30, 2020 | 48.43M |
| March 31, 2020 | 47.77M |
| December 31, 2019 | 46.69M |
| September 30, 2019 | 44.37M |
| June 30, 2019 | 44.71M |
| March 31, 2019 | 39.57M |
| Date | Value |
|---|---|
| December 31, 2018 | 43.77M |
| September 30, 2018 | 40.71M |
| June 30, 2018 | 41.34M |
| March 31, 2018 | 38.43M |
| December 31, 2017 | 42.18M |
| September 30, 2017 | 40.34M |
| June 30, 2017 | 38.80M |
| March 31, 2017 | 33.62M |
| December 31, 2016 | 37.33M |
| September 30, 2016 | 33.94M |
| June 30, 2016 | 33.31M |
| March 31, 2016 | 29.01M |
| December 31, 2015 | 30.45M |
| September 30, 2015 | 28.00M |
| June 30, 2015 | 24.07M |
| March 31, 2015 | 17.37M |
| December 31, 2014 | 14.08M |
| September 30, 2014 | 8.349M |
| June 30, 2014 | 5.742M |
| March 31, 2014 | 0.0279M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-38.40M
Minimum
Dec 2021
68.22M
Maximum
Sep 2021
43.41M
Average
47.77M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
| AtriCure Inc | 106.54M |
| Bio-Rad Laboratories Inc | 681.18M |
| Artivion Inc | 93.67M |
| Shockwave Medical Inc | 202.98M |
| Perspective Therapeutics Inc | -5.239M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -90.17M |
| Total Expenses (Quarterly) | 127.90M |
| EPS Diluted (Quarterly) | -1.18 |
| Enterprise Value | 266.62M |
| Gross Profit Margin (Quarterly) | 89.87% |
| Profit Margin (Quarterly) | -200.1% |
| Earnings Yield | -27.76% |
| Normalized Earnings Yield | -77.82 |